Integrated Advisors Network’s ARK Genomic Revolution ETF ARKG Stock Holding History

Integrated Advisors Network’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6,440	Closed	-$394K	–	658
2021 Q4	$394K	Sell	6,440 -141	-2%	-$9.75K	0.02%	464
2021 Q3	$492K	Buy	6,581 +371	+6%	+$31.1K	0.03%	403
2021 Q2	$574K	Sell	6,210 -19,480	-76%	-$1.66M	0.04%	327
2021 Q1	$2.28M	Sell	25,690 -35,824	-58%	-$3.55M	0.21%	133
2020 Q4	$5.74M	Buy	61,514 +9,934	+19%	+$791K	0.63%	35
2020 Q3	$3.29M	Buy	51,580 +6,873	+15%	+$403K	0.42%	64
2020 Q2	$2.33M	Buy	+44,707	New	+$1.92M	0.27%	106

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Integrated Advisors Network's ARKG Position: Q1 2022 in Review

Integrated Advisors Network sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 6,440 shares — an estimated $394K sold.

Integrated Advisors Network first reported a position in ARKG in Q2 2020 and held it in 7 quarters. The position peaked at $5.74M in Q4 2020. 387 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

Integrated Advisors Network reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
Integrated Advisors Network sold 6,440 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $394K.
Integrated Advisors Network first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 7 quarters.
Integrated Advisors Network's ARK Genomic Revolution ETF position peaked at $5.74M in Q4 2020.
387 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Integrated Advisors Network's 13F filing for Q1 2022, filed 2 May 2022.